Evidence map›Paper›PMID 38791456›Full record

ArticleInternational journal of molecular sciences2024

Presenilin Deficiency Results in Cellular Cholesterol Accumulation by Impairment of Protein Glycosylation and NPC1 Function.

Marietta Fabiano, Naoto Oikawa, Anja Kerksiek, Jun-Ichi Furukawa, Hirokazu Yagi, Koichi Kato, Ulrich Schweizer, Wim Annaert, Jongkyun Kang, Jie Shen and 2 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. RER1 regulates lipid metabolism in monocytes and macrophages.Cellular and molecular life sciences : CMLS · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Marietta FabianoDepartment of Neurology, Universitätsklinikum Bonn, 53127 Bonn, Germany.ORCID 0000-0002-4360-6809
Naoto OikawaDepartment of Neurology, Universitätsklinikum Bonn, 53127 Bonn, Germany.
Anja KerksiekInstitute of Clinical Chemistry and Clinical Pharmacology, Universitätsklinikum Bonn, 53127 Bonn, Germany.
Jun-Ichi FurukawaDepartment of Orthopedic Surgery, Hokkaido University Graduate School of Medicine, Sapporo 060-8638, Japan.ORCID 0000-0002-7284-2261
Hirokazu YagiGraduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya 467-8603, Japan.ORCID 0000-0001-9296-0225
Koichi KatoGraduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya 467-8603, Japan.ORCID 0000-0001-7187-9612
Ulrich SchweizerInstitut für Biochemie und Molekularbiologie, Universitätsklinikum Bonn, Rheinische Friedrich-Wilhelms-Universität Bonn, 53115 Bonn, Germany.ORCID 0000-0003-1380-4780
Wim AnnaertLaboratory for Membrane Trafficking, VIB-Center for Brain and Disease Research, KU Leuven, 3000 Leuven, Belgium.ORCID 0000-0003-0150-9661
Jongkyun KangDepartment of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Jie ShenDepartment of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Dieter LütjohannInstitute of Clinical Chemistry and Clinical Pharmacology, Universitätsklinikum Bonn, 53127 Bonn, Germany.ORCID 0000-0002-7941-8308
Jochen WalterDepartment of Neurology, Universitätsklinikum Bonn, 53127 Bonn, Germany.ORCID 0000-0002-4678-2912

Funding

Role of Presenilins in the SynapseR01NS041783 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI Jie Shen · 2001 to 2026
$10.6M
Development of novel therapies for FADRF1AG063520 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI SHEN, JIE · 2019 to 2019
$3.9M
Deutsche Forschungsgemeinschaft OI 60/1-1Ministry of Education, Culture, Sports, Science and Technology JP21H02625Ministry of Education, Culture, Sports, Science and Technology JP22K07364Ministry of Education, Culture, Sports, Science and Technology JP23H03838National Institutes of Natural Sciences 23EXC336NIA NIH HHS RF1 AG063520NINDS NIH HHS R01 NS041783SAO #20200030SAO #20220022Vlaams Instituut voor Biotechnologie C14/021/095
6 · The paper itself

Abstract

Presenilin proteins (PS1 and PS2) represent the catalytic subunit of γ-secretase and play a critical role in the generation of the amyloid β (Aβ) peptide and the pathogenesis of Alzheimer disease (AD). However, PS proteins also exert multiple functions beyond Aβ generation. In this study, we examine the individual roles of PS1 and PS2 in cellular cholesterol metabolism. Deletion of PS1 or PS2 in mouse models led to cholesterol accumulation in cerebral neurons. Cholesterol accumulation was also observed in the lysosomes of embryonic fibroblasts from Psen1-knockout (PS1-KO) and

Indexed as

CholesterolFibroblastsLysosomesNiemann-Pick C1 ProteinPresenilin-1Presenilin-2Alzheimer DiseaseAnimalsGlycosylationIntracellular Signaling Peptides and ProteinsMiceMice, KnockoutNeuronsCholesterolIntracellular Signaling Peptides and ProteinsNiemann-Pick C1 ProteinNpc1 protein, mousePresenilin-1presenilin 1, mousePresenilin-2Psen2 protein, mousecholesterollysosomeN-glycosylationNPC1Presenilin

Identifiers

PMID38791456
PMCPMC11121565

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.